Business Description
Intrasense
NAICS : 511210
ISIN : FR0011179886
Compare
Compare
Traded in other countries / regions
ALINS.FranceI8S.Germany IPO Date
2012-02-22Description
Intrasense is engaged in developing medical imaging software. It develops & markets Myrian, a multimodality software platform for the review and analysis of latest generation medical images.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 3.06 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.2 | |||||
| Debt-to-EBITDA | -0.56 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.86 | |||||
| Beneish M-Score | -2.87 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -24.7 | |||||
| 3-Year EBITDA Growth Rate | -273.3 | |||||
| 3-Year EPS without NRI Growth Rate | -21.5 | |||||
| 3-Year FCF Growth Rate | -29.2 | |||||
| 3-Year Book Growth Rate | 17.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.22 | |||||
| 9-Day RSI | 35.2 | |||||
| 14-Day RSI | 37.75 | |||||
| 6-1 Month Momentum % | -12.5 | |||||
| 12-1 Month Momentum % | -27.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.49 | |||||
| Quick Ratio | 3.49 | |||||
| Cash Ratio | 2.5 | |||||
| Days Sales Outstanding | 100.95 | |||||
| Days Payable | 565.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -27.6 | |||||
| Shareholder Yield % | -61.3 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 89.08 | |||||
| Operating Margin % | -106.11 | |||||
| Net Margin % | -108.26 | |||||
| FCF Margin % | -150.48 | |||||
| ROE % | -58.33 | |||||
| ROA % | -35.52 | |||||
| ROIC % | -72.28 | |||||
| ROC (Joel Greenblatt) % | -455.67 | |||||
| ROCE % | -46.43 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 4.13 | |||||
| PB Ratio | 1.89 | |||||
| Price-to-Tangible-Book | 3.4 | |||||
| EV-to-EBIT | -3.15 | |||||
| EV-to-EBITDA | -4.19 | |||||
| EV-to-Revenue | 3.37 | |||||
| EV-to-FCF | -2.15 | |||||
| Price-to-Median-PS-Value | 1.81 | |||||
| Price-to-Net-Current-Asset-Value | 4.53 | |||||
| Price-to-Net-Cash | 9.07 | |||||
| Earnings Yield (Greenblatt) % | -31.76 | |||||
| FCF Yield % | -35.04 |
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers